Search results
Results from the WOW.Com Content Network
Treatment for left ventricular hypertrophy depends on the cause. It may include medicines, catheter procedures or surgery. It's important to manage conditions such as high blood pressure and sleep apnea, which can cause blood pressure to be higher.
The results of a perfusion test may inform your doctor how well your heart is functioning and whether or not it is receiving an adequate amount of blood. A nuclear stress test or a myocardial perfusion imaging are two different names for this procedure.
Left ventricular assist device (LVAD): An implantable pump that helps the heart circulate blood. Heart transplant: Procedure to replace a worn-out heart with a healthy one from a donor. This treatment is for patients with the most severe forms of left-sided heart failure.
Left ventricular hypertrophy is a thickening of the wall of the heart's main pumping chamber, called the left ventricle. This thickening may increase pressure within the heart. The condition can make it harder for the heart to pump blood. The most common cause is high blood pressure.
Coronary artery disease (CAD) is the most common cause of left ventricular dysfunction and heart failure (ischemic cardiomyopathy [ICM]). The increasing sophistication of coronary artery bypass grafting (CABG) and percutaneous intervention (PCI) raises important questions about the appropriate role of revascularization, CABG, or PCI in treating ...
Cardiology Journals | Cardiologist Education | Radcliffe Cardiology
Treatment to slow or stop the progression of left ventricular hypertrophy lowers the risk of severe heart damage. An early and accurate diagnosis is the key to improving the outlook for people with left ventricular hypertrophy.
Left ventricular failure can further subdivide into heart failure with preserved ejection fraction (HFpEF with EF over 50%), heart failure with reduced ejection fraction (HFrEF with EF less than 40%), or heart failure with mid-range ejection fraction (EF between 41 and 49 percent).
Approximately 50% of the patients with heart failure have normal, or near-normal left ventricular (LV) systolic heart function with a LV ejection fraction ≥ 50% and a LV end-diastolic volume index < 97 mL/m 2. These patients are described as having heart failure with preserved ejection fraction (HFpEF).
Summarize the treatment and management options available for left ventricular hypertrophy. Review the differential diagnosis and toxicokinetics of left ventricular hypertrophy and the pertinent ongoing trials. Access free multiple choice questions on this topic.